Events are FREE to qualified industry participants and decision-makers.
Technology's Evolution & Impact on Manufacturing Opening Remarks
Jean-Marc Bielser (process technologies innovation, Merck Serono SA, an affiliate of Merck KGaA, Darmstadt, Germany) and moderator Ben Locwin (executive, Black Diamond Networks) discuss how MerckSerono SA implemented the change to CM to address future biomanufacturing challenges.
Dave Backer (Dave Backer, chief commercial officer, Oxford Biomedica) and Ben Locwin (executive, Black Diamond Networks) discuss the difficult and complex business and technology decisions cell and gene therapy must correctly make to accelerate efficiency and speed to market.
Morten Munk (director – global alliance management, FUJIFILM Diosynth Biotechnologies) and Ben Locwin (executive, Black Diamond Networks) discuss his CM experience and how biopharmaceutical companies should approach moving from theoretical to actual implementation.
Parrish Galliher (independent bioprocess consultant) and moderator Ben Locwin (executive, Black Diamond Networks) discuss how he identified the cause and resolved one biopharma company's situation where protein production at scale produced the wrong sequence and changed the protein.
Ron Bates (vice president, development and manufacturing, Immunovant) and Ben Locwin (executive, Black Diamond Networks) discuss the options biopharma companies operating older facilities can implement to reduce the number of environmental hits.
William Whitford (life sciences strategic solutions leader, DPS Group) and moderator Ben Locwin (executive Black Diamond Networks) discuss the current and next-gen technologies necessary to support ATMP process intensification.